1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. Executive Summary
3.1. Outlook in the Spinal Muscular Atrophy Treatment Market
3.2. Opportunities in the Spinal Muscular Atrophy Treatment Market
4. Premium Insight
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter's Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
5. Global Spinal Muscular Atrophy Treatment Market, by Type
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Type 1
5.4. Type 2
5.5. Type 3
5.6. Type 4
6. Global Spinal Muscular Atrophy Treatment Market, by Treatment
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Drug Therapy
6.4. Gene Replacement Therapy
7. Global Spinal Muscular Atrophy Treatment Market, by Route of Administration
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Intrathecal
7.4. Oral
8. Global Spinal Muscular Atrophy Treatment Market, by Geography
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Americas
8.3.1. Overview
8.3.2. Market Sizing & Forecasting
8.3.3. Argentina
8.3.4. Brazil
8.3.5. Canada
8.3.6. Mexico
8.3.7. United States
8.4. Asia-Pacific
8.4.1. Overview
8.4.2. Market Sizing & Forecasting
8.4.3. Australia
8.4.4. China
8.4.5. India
8.4.6. Japan
8.5. Europe, Middle East & Africa
8.5.1. Overview
8.5.2. Market Sizing & Forecasting
8.5.3. France
8.5.4. Germany
8.5.5. Italy
8.5.6. Spain
8.5.7. United Kingdom
9. Competitive Landscape
9.1. 360iResearch FPNV Positioning Matrix for Global Spinal Muscular Atrophy Treatment Market
9.2. Market Vendor Ranking Analysis for Global Spinal Muscular Atrophy Treatment Market
9.3. Competitive News Feed Analysis for Global Spinal Muscular Atrophy Treatment Market
10. Company Usability Profiles
10.1. Biogen Inc.
10.1.1. Overview
10.1.2. Strategy
10.1.3. SWOT
10.2. Cytokinetics, Inc.
10.2.1. Overview
10.2.2. Strategy
10.2.3. SWOT
10.3. Ionis Pharmaceuticals, Inc.
10.3.1. Overview
10.3.2. Strategy
10.3.3. SWOT
10.4. Isis Pharmaceuticals, Inc.
10.4.1. Overview
10.4.2. Strategy
10.4.3. SWOT
10.5. Novartis International AG
10.5.1. Overview
10.5.2. Strategy
10.5.3. SWOT
10.6. F. Hoffmann-La Roche AG
10.7. PTC Therapeutics
10.8. Pfizer Inc.
11. Appendix
11.1. Discussion Guide
11.2. Top Reports
11.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.3. Author Details